Back to ONC

BeOne Medicines Ltd. Long-Term Debt 2015-2026 | ONC

Beta

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is BeOne Medicines Ltd.'s current long-term debt?

BeOne Medicines Ltd. (ONC) annual long-term debt for 2025 was $961.9M, a 477.78% increase from 2024. BeOne Medicines Ltd. long-term debt for the quarter ending March 31, 2026 was $962.5M.

What was BeOne Medicines Ltd.'s long-term debt in 2024?

BeOne Medicines Ltd. annual long-term debt for 2024 was $166.5M, a 15.75% decline from 2023.

What was BeOne Medicines Ltd.'s long-term debt in 2023?

BeOne Medicines Ltd. annual long-term debt for 2023 was $197.6M, a 5.51% decline from 2022.

What is BeOne Medicines Ltd.'s 5-year long-term debt CAGR?

BeOne Medicines Ltd. long-term debt grew at a compound annual growth rate (CAGR) of 39.26% from FY2020 to FY2025, going from $183.6M to $961.9M over 5 years.

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+39.3%
FY2020
$183.6M
→
FY2025
$961.9M
1516171819202122232425
5 years selected
Long-Term Debt History
PeriodValueChangeSource
FY2025$961.9M+477.8%10-K
FY2024$166.5M-15.8%10-K
FY2023$197.6M-5.5%10-K
FY2022$209.1M+3.5%10-K
FY2021$202.1M+10.1%10-K
FY2020$183.6M+120.4%10-K
FY2019$83.3M+104.3%10-K
FY2018$40.8M+342.3%10-K
FY2017$9.2M-46.6%10-K
FY2016$17.3M+179.3%10-K
FY2015$6.2M-10-K
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →